← Back to Search

Electric Stimulation

Electric Stimulation for Cerebral Palsy

N/A
Recruiting
Led By Samuel Lee, PT, PhD
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 assessment points: baseline - pre stimulation cop, and at the end of the session with stimulation (day 1)- post stimulation cop
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether electrical stimulation can help people with CP maintain balance during tasks like standing up and walking, which may improve function and reduce falls.

Who is the study for?
This trial is for children and young adults aged 8-24 with Cerebral Palsy (CP), specifically those who can stand up from a chair and walk but have difficulty maintaining balance. They should not have other neurological or musculoskeletal disorders, be seizure-free or have well-controlled seizures, and possess sufficient cognitive skills to communicate discomfort.
What is being tested?
The study tests if light electrical stimulation called Stochastic Resonance Electric Stimulation on leg muscles helps improve balance during tasks like standing up, walking, turning around, and sitting down. Participants will perform these activities while receiving imperceptible electric stimulation to enhance sensory perception.
What are the potential side effects?
Since the electrical stimulation is very low intensity and cannot be felt by participants, no significant side effects are expected. However, there may be minimal risks associated with any form of electrical treatment such as skin irritation at the site of electrode placement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 assessment points: baseline - pre stimulation com, and at the end of the session with stimulation (day 1)- post stimulation com
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 assessment points: baseline - pre stimulation com, and at the end of the session with stimulation (day 1)- post stimulation com for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in COM
Change in COP
Total time

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stochastic Resonance stimulationExperimental Treatment1 Intervention
During this condition, participants will perform postural transitions like sit to stand, gait initiation, sit to walk and Timed Up and Go test while receiving stochastic resonance stimulation on legs and hip.
Group II: No Stochastic Resonance stimulationActive Control1 Intervention
During this condition, participants will perform postural transitions like sit to stand, gait initiation, sit to walk and Timed Up and Go test without receiving any electrical stimulation.

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
162 Previous Clinical Trials
25,586 Total Patients Enrolled
5 Trials studying Cerebral Palsy
262 Patients Enrolled for Cerebral Palsy
Samuel Lee, PT, PhDPrincipal InvestigatorUniversity of Dealware
2 Previous Clinical Trials
52 Total Patients Enrolled
2 Trials studying Cerebral Palsy
52 Patients Enrolled for Cerebral Palsy

Media Library

Stochastic Resonance Electric Stimulation (Electric Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05384990 — N/A
Cerebral Palsy Research Study Groups: Stochastic Resonance stimulation, No Stochastic Resonance stimulation
Cerebral Palsy Clinical Trial 2023: Stochastic Resonance Electric Stimulation Highlights & Side Effects. Trial Name: NCT05384990 — N/A
Stochastic Resonance Electric Stimulation (Electric Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05384990 — N/A
Cerebral Palsy Patient Testimony for trial: Trial Name: NCT05384990 — N/A
~11 spots leftby May 2025